Health tech startup Aide Health has secured $1.2m in pre-seed funding to help patients manage long-term conditions.
The funding was led by Hambro Perks through its EIS fund, with participation from Fuel Ventures, 1818 Ventures and APX.
Aide Health’s digital platform is currently being used in the NHS. A pilot was launched earlier this year, with the platform being trialled for patients with asthma or type 2 diabetes.
The platform is used by clinicians to create and remotely monitor health plans for people with chronic disease. This is teamed with a mobile app for the patients, which acts as a 24/7 companion to support their prescribed care.
Ian Wharton, co-founder and CEO at Aide Health, said: “Our goal is to give both patients and clinicians the tools and insights they need to have better conversations and make more informed treatment decisions together. The pilot in NHS England is our first step towards making Aide available to everyone with chronic illness.”
The technology works by using short, daily conversations to help with the management of health conditions through medicines optimisation, structured monitoring and education.
Nicholas Sharp, head of Hambro Perks Growth EIS Fund, said: “We believe that Aide Health has the potential to be a hugely important tool for both clinicians and patients for managing long-term health conditions.
“Hambro Perks has a long track record of backing health tech companies as part of our aim to invest in companies that make the world a better place. Aide Health and Ian’s team were therefore an obvious choice for us, and we look forward to supporting them on their growth journey.”
Aide Health will be launching pathways for hypertension and chronic pain in the near future. The organisation is one of many to have received funding boosts in the digital health world this year.
Back in October, we reported that a £1.8million funding boost has been given to the Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) to go towards exploring regulation of digital mental health tools.